Haphazard policy pronouncements cost Zim critical investment flows NewsbyJuly 1, 20255 minute readNo comments
News PainReform Shares Surge in Registered Direct Offering By Chris Wack Summary PainReform, a clinical-stage therapeutics reformulation company, saw its shares surge 19% to $9.65 on… supervisorAugust 20, 2023 Read More
